Manufacture and characteristics of asymmetric membrane capsule shells with a novel wet phase inversion method

References

• Wang CY, Ho HO, Lin LH, et al. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects. Int J Pharm 2005;297:89–97
   PubMed Web of Science ®Google Scholar
• Choudhury PK, Ranawat MS, Pillai MK, Chauhan CS. Asymmetric membrane capsule for osmotic delivery of flurbiprofen. Acta Pharm 2007;57:343–50
   PubMedGoogle Scholar
• Garg A, Gupta M, Bhargava HN. Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets. Eur J Pharm Biopharm 2007;67:725–31
   PubMed Web of Science ®Google Scholar
• Deepak G, Kilambi P. The fabrication and evaluation of the formulation variables of a controlled-porosity osmotic drug delivery system with diltiazem hydrochloride. Pharm Technol 2003;27:58–68
   Google Scholar
• Am Ende MT, Miller LA. Mechanistic investigation of drug release from asymmetric membrane tablets: effect of media gradients (osmotic pressure and concentration), and potential coating failures on in vitro release. Pharm Res 2007;24:288–97
   PubMed Web of Science ®Google Scholar
• Thombre AG, DeNoto AR, Gibbes DC. Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients. J Control Release 1999;60:333–41
   PubMed Web of Science ®Google Scholar
• Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release 2002;79:7–27
   PubMed Web of Science ®Google Scholar
• Waterman KC, Goeken GS, Konagurthu S, et al. Osmotic capsules: a universal oral, controlled-release drug delivery dosage form. J Control Release 2011;152:264–9
   PubMed Web of Science ®Google Scholar
• Thombre AG, Cardinal JR, DeNoto AR, et al. Asymmetric membrane capsules for osmotic drug delivery: I. development of a manufacturing process. J Control Release 1999;57:55–64
   PubMed Web of Science ®Google Scholar
• Fu HX, Li H, Zhang FZ, et al. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro. Drug Dev Ind Pharm 2012;38:670–8
   PubMed Web of Science ®Google Scholar
• Altinkaya SA, Ozbas B. Modeling of asymmetric membrane formation by dry-casting method. J Membr Sci 2007;230:71–89
   Web of Science ®Google Scholar
• Wang GM, Chen CH, Ho HO, et al. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice. Int J Pharm 2006;319:71–81
   PubMed Web of Science ®Google Scholar
• Chauhan CS, Ranawat MS, Choudhury PK. Fabrication and evaluation of asymmetric membrane osmotic pump. Indian J Pharm Sci 2007;69:748–52
   Google Scholar
• Philip AK, Pathak K, Shakya P. Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil. Eur J Pharm Biopharm 2008;69:658–66
   PubMed Web of Science ®Google Scholar
• Guan J, Zhou L, Pan Y, et al. A novel gastro-retentive osmotic pump capsule using asymmetric membrane technology: in vitro and in vivo evaluation. Pharmaceut Res 2010;27:105–14
   PubMed Web of Science ®Google Scholar
• Chauhan CS, Choudhury PK. Controlled porosity osmotic pump for the delivery of flurbiprofen. Curr Drug Deliv 2006;3:193–8
   PubMedGoogle Scholar
• Choudhury PK, Chauhan CS, Ranawat MS. Osmotic delivery of flurbiprofen through controlled porosity asymmetric membrane capsule. Drug Dev Ind Pharm 2007;33:1135–41
   PubMed Web of Science ®Google Scholar
• Philip AK, Pathak K. Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility. AAPS Pharm Sci Tech 2006;7:E1--E11
   PubMed Web of Science ®Google Scholar
• Philip AK, Pathak K. Wet process-induced phase-transited drug delivery system: a means for achieving osmotic, controlled, and level A IVIVC for poorly water-soluble drug. Drug Dev Ind Pharm 2008;34:735–43
   PubMed Web of Science ®Google Scholar
• Philip AK. Osmotically regulated flow of flurbiprofen through in situ formed asymmetric membrane capsule. Curr Drug Deliv 2008;5:127–32
   PubMedGoogle Scholar
• Philip A, Pathak K. In situ formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug. PDA J Pharm Sci Technol 2007;61:24–36
   PubMedGoogle Scholar
• Philip AK, Pathak K. In situ formed phase transited drug delivery system of Ketoprofen for achieving osmotic, controlled and level A in vitro in vivo correlation. Indian J Pharm Sci 2008;70:745–53
   PubMed Web of Science ®Google Scholar
• Guarve K, Gupta GD. Asymmetric membrane capsules for extended delivery of the weakly basic drug Carvedilol. Pharmaceutics 2010;2:199–208
   PubMedGoogle Scholar
• Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. Asymmetric-membrane tablet coatings for osmotic drug delivery. J Control Release 1995;35:127–36
   Web of Science ®Google Scholar
• Barmpalexis P, Kachrimanis K, Georgarakis E. Solid dispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming. Eur J Pharm Biopharm 2011;77:122–31
   PubMed Web of Science ®Google Scholar
• Verma RK, Mishra B. Studies on formulation and evaluation of oral osmotic pumps of nimesulide. Pharmazie 1999;54:74–5
   Web of Science ®Google Scholar
• Geerke JH. Method and apparatus for forming dispenser delivery ports; 1997. US Patent 5,658,474
   Google Scholar
• Liu L, Xu X. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet. Int J Pharm 2008;352:225–30
   PubMed Web of Science ®Google Scholar
• Chaudhary A, Tiwari N, Jain V, Singh R. Microporous bilayer osmotic tablet for colon-specific delivery. Eur J Pharm Biopharm 2011;78:134–40
   PubMed Web of Science ®Google Scholar
• Lin YK, Ho HO. Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice. J Control Release 2003;89:57–69
   PubMed Web of Science ®Google Scholar
• Tang X, Tai LY, Yang XG, et al. In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions. Drug Dev Ind Pharm 2013;39:67–76
   PubMed Web of Science ®Google Scholar
• Thombre AG, Cardinal JR, DeNoto AR, Gibbes DC. Asymmetric membrane capsules for osmotic drug delivery: II. in vitro and in vivo drug release performance. J Control Release 1999;57:65–73
   PubMed Web of Science ®Google Scholar
• McClelland GA, Sutton SC, Engle K, Zentner GM. The solubility-modulated osmotic pump: in vitro/in vivo release of diltiazem hydrochloride. Pharm Res 1991;8:88–92
   PubMed Web of Science ®Google Scholar
• Zentner GM. McClelland GA, Sutton SC. Controlled porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride. J Control Release 1991;16:237–44
   Web of Science ®Google Scholar
• Fu JJ, Xu LS, Wang XL, et al. Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm 2011;37:934–44
   PubMed Web of Science ®Google Scholar
• Tuntikulwattana S, Sinchaipanid N, Ketjinda W, et al. Fabrication of chitosan-polyacrylic acid complexes as polymeric osmogents for swellable micro/nanoporous osmotic pumps. Drug Dev Ind Pharm 2011;37:926–33
   PubMed Web of Science ®Google Scholar
• Altinkaya SA, Yenal H. In vitro drug release rates from asymmetric-membrane tablet coatings, Prediction of phase-inversion dynamics. Biochem Eng J 2006;28:131–9
   Web of Science ®Google Scholar
• Choudhury PK, Ranawat MS, Pillai MK, Chauhan CS. Asymmetric membrane capsule for osmotic delivery of flurbiprofen. Acta Pharm 2007;57:343–50
   PubMedGoogle Scholar